Identification of a RhoA- and SRF-Dependent Mechanism of Androgen Action that is Associated with Prostate Cancer Progression

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|4|481-489

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.4, 2013-04, pp. : 481-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen Receptor Gene Rearrangements: New Perspectives on Prostate Cancer Progression

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 441-449

Bentham Science Publishers

Access to resources Recommend Favorite

Resveratrol Antagonizes EGFR-Dependent Erk1/2 Activation in Human Androgen-Independent Prostate Cancer Cells with Associated Isozyme-Selective PKCα Inhibition

By Stewart Jubilee R.   O'Brian Catherine A.  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 107-117

Springer Publishing Company

Access to resources Recommend Favorite

Hypoxia and Inflammation in Prostate Cancer Progression. Cross-talk with Androgen and Estrogen Receptors and Cancer Stem Cells

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 4, 2017-02 ,pp. : 235-248

Bentham Science Publishers

Access to resources Recommend Favorite

Sipuleucel-T [Provenge] prolongs prostate-specific antigen (PSA) doubling time in patients with androgen-dependent prostate cancer

By  

Inpharma, Vol. 1, Iss. 1564, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer

By Singer Eric A   Golijanin Dragan J   Miyamoto Hiroshi   Messing Edward M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite